Approval · Notice of Compliance 12528 · 2011
NTP-ACYCLOVIR: Notice of Compliance 12528
Issued August 3, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12528
- Date
- August 3, 2011
- Company
- Nt Pharma Canada LtdStouffville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New Manufacturer and Product Name
- Therapeutic class
- Antiviral Agent
- Canadian reference product
- ZOVIRAX (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NTP-ACYCLOVIR | 02367513 | Cancelled Pre Market |
| NTP-ACYCLOVIR | 02367521 | Cancelled Pre Market |
| NTP-ACYCLOVIR | 02367548 | Cancelled Pre Market |